|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 35/28 | (2015.01) |
| A61K 31/192 | (2013.01) | ||
| C12N 5/0789 | (2010.01) | ||
| A61K 35/28 | (2013.01) | ||
| A61P 9/00 | (2006.01) | ||
| C12N 5/0663 | (2013.01) | ||
| A61P 9/10 | (2006.01) | ||
| C12N2501/02 | (2013.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 9/10 | (2018.01) | ||
| A61P 9/14 | (2018.01) |
| (11) | Patento numeris | 3534917 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17808627.8 |
| Europos patento paraiškos padavimo data | 2017-10-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-09-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-08-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2017/057863 |
| Data | 2017-10-23 |
| (87) | Numeris | WO 2018/080990 |
| Data | 2018-05-03 |
| (30) | Numeris | Data | Šalis |
| 201662411950 P | 2016-10-24 | US |
| (72) |
ILAGAN, Roger Marquez , US
HOGAN, Sarah , US
CHEADLE, John B. , US
|
| (73) |
United Therapeutics Corporation ,
1040 Spring Street, Silver Spring, MD 20910,
US
|
| (54) | ENHANCEMENT OF MSC IMMUNOMODULATORY PROPERTIES BY TREPROSTINIL |
| ENHANCEMENT OF MSC IMMUNOMODULATORY PROPERTIES BY TREPROSTINIL |